An imbalance between angiogenic and antiangiogenic factors in pregnancy has been suggested as a risk factor for the subsequent development of pre-eclampsia. A new study in pregnant women with type 1 diabetes mellitus indicates that these factors may be used as predictive biomarkers for pre-eclampsia.